The Phosphatase Inhibitor Menadione (Vitamin K3) protects cells from EGFR Inhibition by Erlotinib and Cetuximab (Clinical Cancer Research (2011) 1)

Roman Perez-Soler, Yiyu Zou, Tianhong Li, Yi He Ling

Research output: Contribution to journal › Article

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)4901
Number of pages1
JournalClinical Cancer Research
Volume19
Issue number17
DOIs
StatePublished - Sep 1 2013
Externally publishedYes

Fingerprint

Vitamin K 3
Phosphoric Monoester Hydrolases
Research
Neoplasms
Erlotinib Hydrochloride
Cetuximab

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

The Phosphatase Inhibitor Menadione (Vitamin K3) protects cells from EGFR Inhibition by Erlotinib and Cetuximab (Clinical Cancer Research (2011) 1). / Perez-Soler, Roman; Zou, Yiyu; Li, Tianhong; Ling, Yi He.

In: Clinical Cancer Research, Vol. 19, No. 17, 01.09.2013, p. 4901.

Research output: Contribution to journal › Article

Perez-Soler, R, Zou, Y, Li, T & Ling, YH 2013, 'The Phosphatase Inhibitor Menadione (Vitamin K3) protects cells from EGFR Inhibition by Erlotinib and Cetuximab (Clinical Cancer Research (2011) 1)', Clinical Cancer Research, vol. 19, no. 17, pp. 4901. https://doi.org/10.1158/1078-0432.CCR-13-1912
Perez-Soler R, Zou Y, Li T, Ling YH. The Phosphatase Inhibitor Menadione (Vitamin K3) protects cells from EGFR Inhibition by Erlotinib and Cetuximab (Clinical Cancer Research (2011) 1). Clinical Cancer Research. 2013 Sep 1;19(17):4901. https://doi.org/10.1158/1078-0432.CCR-13-1912
Perez-Soler, Roman ; Zou, Yiyu ; Li, Tianhong ; Ling, Yi He. / The Phosphatase Inhibitor Menadione (Vitamin K3) protects cells from EGFR Inhibition by Erlotinib and Cetuximab (Clinical Cancer Research (2011) 1). In: Clinical Cancer Research. 2013 ; Vol. 19, No. 17. pp. 4901.
@article{4d041d20cc3f460ea699ba1b0bff73e4,
title = "The Phosphatase Inhibitor Menadione (Vitamin K3) protects cells from EGFR Inhibition by Erlotinib and Cetuximab (Clinical Cancer Research (2011) 1)",
author = "Roman Perez-Soler and Yiyu Zou and Tianhong Li and Ling, {Yi He}",
year = "2013",
month = "9",
day = "1",
doi = "10.1158/1078-0432.CCR-13-1912",
language = "English (US)",
volume = "19",
pages = "4901",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "17",

}

TY - JOUR

T1 - The Phosphatase Inhibitor Menadione (Vitamin K3) protects cells from EGFR Inhibition by Erlotinib and Cetuximab (Clinical Cancer Research (2011) 1)

AU - Perez-Soler, Roman

AU - Zou, Yiyu

AU - Li, Tianhong

AU - Ling, Yi He

PY - 2013/9/1

Y1 - 2013/9/1

UR - http://www.scopus.com/inward/record.url?scp=84883483956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883483956&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-13-1912

DO - 10.1158/1078-0432.CCR-13-1912

M3 - Article

C2 - 24003062

AN - SCOPUS:84883483956

VL - 19

SP - 4901

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 17

ER -

Access to Document